These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17717263)

  • 41. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block.
    Groudine SB; Soto R; Lien C; Drover D; Roberts K
    Anesth Analg; 2007 Mar; 104(3):555-62. PubMed ID: 17312208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of Sugammadex in an octagenerian with Myaesthenia Gravis undergoing emergency laporotomy.
    Shah D; Dharmarajah A
    J Clin Anesth; 2017 Feb; 37():109-110. PubMed ID: 28235495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversal of neuromuscular blockade by sugammadex in laparoscopic bariatric surgery: In support of dose reduction.
    Badaoui R; Cabaret A; Alami Y; Zogheib E; Popov I; Lorne E; Dupont H
    Anaesth Crit Care Pain Med; 2016 Feb; 35(1):25-29. PubMed ID: 26597732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The presumed central nervous system effects of rocuronium in a neonate and its reversal with sugammadex.
    Langley RJ; McFadzean J; McCormack J
    Paediatr Anaesth; 2016 Jan; 26(1):109-11. PubMed ID: 26456087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal dosage of adamgammadex for reversal of rocuronium-induced neuromuscular block: a preliminary meta-analysis.
    Chen IW; Yu TS; Hung KC
    Syst Rev; 2024 Sep; 13(1):240. PubMed ID: 39304936
    [No Abstract]   [Full Text] [Related]  

  • 46. Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: a randomised controlled study in healthy volunteers.
    Schepens T; Cammu G; Saldien V; De Neve N; Jorens PG; Foubert L; Vercauteren M
    Eur J Anaesthesiol; 2015 Jan; 32(1):49-57. PubMed ID: 25111539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of dexamethasone on sugammadex reversal times of rocuronium: a systematic review protocol.
    Held CR; Sullivan MD
    JBI Database System Rev Implement Rep; 2017 Jun; 15(6):1543-1551. PubMed ID: 28628514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal anesthetic regimen for ambulatory laser microlaryngeal surgery.
    Huh H; Park SJ; Lim HH; Jung KY; Baek SK; Yoon SZ; Lee HW; Lim HJ; Cho JE
    Laryngoscope; 2017 May; 127(5):1135-1139. PubMed ID: 27796041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Case of anesthesia for thoracoscopic thymectomy in a pediatric patient with myasthenia gravis: reversal of rocuronium-induced neuromuscular blockade with sugammadex].
    Takeda A; Kawamura M; Hamaya I; Kitamura H; Muto R; Mitono H
    Masui; 2012 Aug; 61(8):855-8. PubMed ID: 22991811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of sugammadex in a patient with myasthenia gravis.
    Unterbuchner C; Fink H; Blobner M
    Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sugammadex: the first selective binding reversal agent for neuromuscular block.
    Kovac AL
    J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of rocuronium and sugammadex in a patient with a history of suxamethonium allergy.
    Messer B; Wilkes J
    Anaesthesia; 2011 Sep; 66(9):844. PubMed ID: 21831084
    [No Abstract]   [Full Text] [Related]  

  • 54. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
    Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
    Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Rapid sequence induction in a patient with Steinert myotonic dystrophy: Interest of the association of high doses of rocuronium and sugammadex].
    Pellegrini L; Mercier MF; Cornese A; Blasco V; Albanèse J
    Ann Fr Anesth Reanim; 2012 Feb; 31(2):155-7. PubMed ID: 22154451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure of sugammadex to reverse rocuronium-induced neuromuscular blockade: a case report.
    Ortiz-Gómez JR; Palacio-Abizanda FJ; Fornet-Ruiz I
    Eur J Anaesthesiol; 2014 Dec; 31(12):708-9. PubMed ID: 24718022
    [No Abstract]   [Full Text] [Related]  

  • 59. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex. Findings vs. speculation.
    Carron M; Ori C
    Acta Anaesthesiol Scand; 2015 Aug; 59(7):946-7. PubMed ID: 25962433
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment.
    Panhuizen IF; Gold SJ; Buerkle C; Snoeck MM; Harper NJ; Kaspers MJ; van den Heuvel MW; Hollmann MW
    Br J Anaesth; 2015 May; 114(5):777-84. PubMed ID: 25829395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.